Abstract:Objective Preliminary evaluation of the safety and efficiency of alkylated low molecular polyethylenimine as a gene delivery vector. <br> Methods bPEI1.8K-C12 was synthesized with branch PEI (Mw 1800; bPEI1.8K) and 1-bromododecane, and structurally confirmed with 1H-NMR. Cytotoxicity and biocompatibility of bPEI1.8K-C12 were evaluated by MTT method and hemolysis assay, respectively. Size distribution and zeta potential of bPEI1.8K-C12/DNA polyplexes were determined, and cellular uptake of the DNA polyplexes was visualized with confocal laser scanning microscope (CLSM). DNA condensation ability of bPEI1.8K-C12 was studied by gel retardation assay, and in vitro gene delivery efficiency was investigated with luciferase and green fluorescent protein reporter gene, respectively. <br> Results bPEI1.8K-C12 was successfully synthesized after confirmation by 1H-NMR. Cytotoxicity of bPEI1.8K-C12 on MCF-7 cells was as low as bPEI1.8K, and systematic delivery of high dose bPEI1.8K-C12 may cause hemolysis in vivo. The average size of bPEI1.8K-C12/DNA polyplexes was bigger than that of bPEI1.8K/DNA polyplexes at the same weight ratio, and the zeta potential of bPEI1.8K-C12/DNA polyplexes was higher than that of bPEI1.8K/DNA polyplexes at the same weight ratio. After alkylation, the DNA condensation ability of bPEI1.8K-C12 was reduced, but the cellular uptake of bPEI1.8K-C12/DNA polyplexes was greatly enhanced. In vitro gene transfection efficiency of bPEI1.8K-C12/DNA was significantly higher than that of bPEI1.8K, and was comparable to that of lipofectamine2000. <br> Conclusion bPEI1.8K-C12 is a safe and efficient gene delivery vector, and holds great promise for further development.

Alkylated low molecular polyethylenimine as a gene delivery vector